Please login to the form below

Not currently logged in
Email:
Password:

Ehlers-Danlos syndrome

This page shows the latest Ehlers-Danlos syndrome news and features for those working in and with pharma, biotech and healthcare.

Acer Therapeutics hit by FDA filing rejection

Acer Therapeutics hit by FDA filing rejection

Shares plunge as regulator calls for new trial. The FDA has refused to accept the filing of a rare disease treatment for vascular Ehlers-Danlos syndrome (vEDS)   from Acer Therapeutics. ... Edsivo is being developed for vascular Ehlers-Danlos syndrome

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M&F Health

M&F Health is a full service communications agency, dedicated to the health and wellbeing sector. We are an independent amongst...

Latest intelligence

The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
real world studies
The evolution of real-world studies
How industry and regulators are using real-world data...

Infographics